| Product Code: ETC13321818 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Hospital Acquired Disease Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Hospital Acquired Disease Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Hospital Acquired Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Hospital Acquired Disease Testing Market - Industry Life Cycle |
3.4 North America Hospital Acquired Disease Testing Market - Porter's Five Forces |
3.5 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By Infection Type, 2021 & 2031F |
3.7 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America Hospital Acquired Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Hospital Acquired Disease Testing Market Trends |
6 North America Hospital Acquired Disease Testing Market, 2021 - 2031 |
6.1 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Urinary Tract Infections, 2021 - 2031 |
6.1.3 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Surgical Site Infections, 2021 - 2031 |
6.1.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Ventilator-associated Pneumonia, 2021 - 2031 |
6.1.5 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Bloodstream Infections, 2020 - 2028 |
6.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By PCR-based Diagnostics, 2021 - 2031 |
6.2.3 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Rapid Immunoassays, 2021 - 2031 |
6.2.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Culture-based Methods, 2021 - 2031 |
6.2.5 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Molecular Diagnostics, 2021 - 2031 |
6.3 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.3.3 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Intensive Care Units, 2021 - 2031 |
6.3.5 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Pathology Laboratories, 2021 - 2031 |
6.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Nosocomial Infection Detection, 2021 - 2031 |
6.4.3 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Postoperative Care, 2021 - 2031 |
6.4.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Respiratory Infection Screening, 2020 - 2028 |
6.4.5 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Sepsis and Bacteremia Detection, 2020 - 2028 |
7 North America Hospital Acquired Disease Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.1 United States (US) Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.2 Canada Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.3 Rest of North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.3 North America Hospital Acquired Disease Testing Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
7.3.1 United States (US) Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.2 Canada Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.3 Rest of North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.4 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America Hospital Acquired Disease Testing Market Key Performance Indicators |
9 North America Hospital Acquired Disease Testing Market - Export/Import By Countries Assessment |
10 North America Hospital Acquired Disease Testing Market - Opportunity Assessment |
10.1 North America Hospital Acquired Disease Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Hospital Acquired Disease Testing Market Opportunity Assessment, By Infection Type, 2021 & 2031F |
10.3 North America Hospital Acquired Disease Testing Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
10.4 North America Hospital Acquired Disease Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Hospital Acquired Disease Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America Hospital Acquired Disease Testing Market - Competitive Landscape |
11.1 North America Hospital Acquired Disease Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Hospital Acquired Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here